<?xml version="1.0" encoding="UTF-8"?>
<urlset xmlns="http://www.sitemaps.org/schemas/sitemap/0.9"
  xmlns:news="http://www.google.com/schemas/sitemap-news/0.9"
  xmlns:image="http://www.google.com/schemas/sitemap-image/1.1">
  <url>
    <loc>https://researchpepnews.com/articles/peptides-vs-steroids-cjc1295-ipamorelin-sermorelin</loc>
    <news:news>
      <news:publication>
        <news:name>Research Pep News</news:name>
        <news:language>en</news:language>
      </news:publication>
      <news:publication_date>2026-08-01</news:publication_date>
      <news:title>Are Peptides Safer Than Steroids? The Case for CJC-1295, Ipamorelin and Sermorelin</news:title>
    </news:news>
    <image:image>
      <image:loc>https://researchpepnews.com/images/editorial/peptides-vs-steroids-growth-hormone-lab.jpg</image:loc>
      <image:caption>A laboratory technician transfers liquid into a glass sample tube with a micropipette at a lab bench. The scene reflects the hormone and safety testing needed to compare endocrine drugs by evidence rather than marketing. Photo by Nathan Rimoux, published on Unsplash on May 26, 2025.</image:caption>
    </image:image>
  </url>
  <url>
    <loc>https://researchpepnews.com/articles/tesamorelin-vs-cjc-1295-visceral-fat</loc>
    <news:news>
      <news:publication>
        <news:name>Research Pep News</news:name>
        <news:language>en</news:language>
      </news:publication>
      <news:publication_date>2026-08-01</news:publication_date>
      <news:title>Tesamorelin vs. CJC-1295 With and Without DAC: Could Different GH Patterns Produce the Same Visceral-Fat Effect?</news:title>
    </news:news>
    <image:image>
      <image:loc>https://researchpepnews.com/images/editorial/tesamorelin-vs-cjc-1295-visceral-fat.png</image:loc>
      <image:caption>A medical illustration separates tesamorelin’s measured visceral-fat result from the two CJC-1295 hypotheses: sustained GH and IGF-1 exposure with DAC, and a short bedtime-aligned pulse without DAC. The comparison shows which findings come from human studies and which remain community hypotheses. Image: Research Pep News.</image:caption>
    </image:image>
  </url>
  <url>
    <loc>https://researchpepnews.com/articles/overseas-peptide-supply-chain-quality-traceability</loc>
    <news:news>
      <news:publication>
        <news:name>Research Pep News</news:name>
        <news:language>en</news:language>
      </news:publication>
      <news:publication_date>2026-07-31</news:publication_date>
      <news:title>From an Overseas Factory to a Research Vial: The Missing Links in Peptide Quality</news:title>
    </news:news>
    <image:image>
      <image:loc>https://researchpepnews.com/images/editorial/peptide-receiving-chain-of-custody-3ml.png</image:loc>
      <image:caption>A laboratory scientist checks a bulk peptide container against receiving records before material moves into three short 3 mL serum vials. Every handoff needs a batch identity and a documented chain of custody. Image: Research Pep News.</image:caption>
    </image:image>
  </url>
  <url>
    <loc>https://researchpepnews.com/articles/bpc157-blood-pressure-research</loc>
    <news:news>
      <news:publication>
        <news:name>Research Pep News</news:name>
        <news:language>en</news:language>
      </news:publication>
      <news:publication_date>2026-07-31</news:publication_date>
      <news:title>BPC-157 and Blood Pressure: What the Research Actually Tells Us</news:title>
    </news:news>
    <image:image>
      <image:loc>https://researchpepnews.com/images/editorial/bpc157-blood-pressure-evidence-review.png</image:loc>
      <image:caption>A clinician measures a seated adult’s blood pressure with an upper-arm cuff in an exam room. Published BPC-157 research does not establish how the peptide affects blood pressure in people. Image: Research Pep News.</image:caption>
    </image:image>
  </url>
</urlset>